{
  "figure_1": "HR positive/HER2-negative early breast cancer algorithm. AI: aromatase inhibitors; BCS: breast conservation; CT: chemotherapy; ET: endocrine therapy; N: axillar node; OFS: ovarian function suppression; y: years; +:  positive; -: negative. *Consider in premenopausal patients with luminal A-like tumors and no indication for chemotherapy, who are not candidates for optimal surgery, OFS plus an aromatase inhibitor can be considered",
  "figure_2": "HER2-positive early breast cancer algorithm. CT: chemotherapy. pCR: pathologic complete response. (1) This treatment is still awaiting financial approval from the health authorities in Spain",
  "figure_3": "Triple negative early breast cancer algorithm. CT: chemotherapy. pCR: pathologic complete response"
}